UA97521C2 - и-РНК-АГЕНТ, КОТОРЫЙ ОПОСРЕДУЕТ ИНГИБИРОВАНИЕ ЭКСПРЕССИИ АЛЬФА-EnaC - Google Patents

и-РНК-АГЕНТ, КОТОРЫЙ ОПОСРЕДУЕТ ИНГИБИРОВАНИЕ ЭКСПРЕССИИ АЛЬФА-EnaC

Info

Publication number
UA97521C2
UA97521C2 UAA200913031A UAA200913031A UA97521C2 UA 97521 C2 UA97521 C2 UA 97521C2 UA A200913031 A UAA200913031 A UA A200913031A UA A200913031 A UAA200913031 A UA A200913031A UA 97521 C2 UA97521 C2 UA 97521C2
Authority
UA
Ukraine
Prior art keywords
alpha
downregulation
rna
agent modulating
enac expression
Prior art date
Application number
UAA200913031A
Other languages
English (en)
Ukrainian (uk)
Inventor
Хеке Джино Ван
Эмма Хикмен
Хенри Льюк Денехей
Памела Тан
Анке Гейк
Ханс-Петер Форнлокер
Original Assignee
Новартис Аг
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Новартис Аг filed Critical Новартис Аг
Priority claimed from PCT/EP2008/057476 external-priority patent/WO2008152131A2/en
Publication of UA97521C2 publication Critical patent/UA97521C2/ru

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

Изобретение относится к и-РНК-агенту, содержащему первую и вторую цепь, где и-РНК-агент направлен на альфа-EnaC и опосредует активность si-РНК.
UAA200913031A 2007-06-15 2008-06-13 и-РНК-АГЕНТ, КОТОРЫЙ ОПОСРЕДУЕТ ИНГИБИРОВАНИЕ ЭКСПРЕССИИ АЛЬФА-EnaC UA97521C2 (ru)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP07110376 2007-06-15
PCT/EP2008/057476 WO2008152131A2 (en) 2007-06-15 2008-06-13 Rnai inhibition of alpha-enac expression

Publications (1)

Publication Number Publication Date
UA97521C2 true UA97521C2 (ru) 2012-02-27

Family

ID=43038342

Family Applications (1)

Application Number Title Priority Date Filing Date
UAA200913031A UA97521C2 (ru) 2007-06-15 2008-06-13 и-РНК-АГЕНТ, КОТОРЫЙ ОПОСРЕДУЕТ ИНГИБИРОВАНИЕ ЭКСПРЕССИИ АЛЬФА-EnaC

Country Status (2)

Country Link
UA (1) UA97521C2 (ru)
ZA (1) ZA200908301B (ru)

Also Published As

Publication number Publication date
ZA200908301B (en) 2010-08-25

Similar Documents

Publication Publication Date Title
SG169988A1 (en) Rnai inhibition of alpha-enac expression
EP1824872A4 (en) RNAI MODULATION OF MLL-AF4 AND USES THEREOF
MX345909B (es) Anticuerpos anti-fgfr3 y métodos que los utilizan.
WO2006036916A3 (en) Rnai modulation of apob and uses thereof
JO2778B1 (en) Certain vehicles, installations and methods
IN2012DN03883A (ru)
MY153915A (en) Organic compounds
JO3118B1 (ar) تراكيب وطرق لبروتين c5 المتمم يستهدف الأجسام المضادة
WO2010048358A3 (en) Ethoxyphenylmethyl inhibitors of sglt2
EA200970580A1 (ru) Таннат разагилина
MX338884B (es) Composiciones y metodos que comprenden variantes de proteasa.
WO2007014077A3 (en) Rnai modulation of the rho-a gene and uses thereof
HK1149950A1 (en) Novel compositions and related methods, coatings, and articles
MX2012004780A (es) Inhibidores de akt.
MX2011014019A (es) Derivados de diazahomoadamantano y sus metodos de uso.
MY173526A (en) Novel anti-?5?1 antibodies and uses thereof
MX2009005829A (es) Polialquileniminas hidrofobicamente modificadas para usarse como inhibidores de transferencia de colorante.
CO6241120A2 (es) (DIHIDRO)PIRROLO[2,1-á]ISOQUINOLINAS.
WO2011160052A3 (en) Methods and compositions for sequence specific rna endonucleases
TW200738751A (en) Anti-EphrinB2 antibodies and methods using same
MX2009004983A (es) Pirazoles sustituidos, composiciones que los contienen, procedimiento de fabricacion y utilizacion.
UA103197C2 (ru) Применение нифуртимокса для лечения болезней, вызванных трихомонадами
WO2010068717A3 (en) Pyrazolinone scavengers of free radicals
AU2018256632A1 (en) RNAi inhibition of alpha-ENaC expression
UA34487U (en) Aquananomagnesium